{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:18:03Z","timestamp":1792815483422,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.phrs.2020.104861","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T12:50:44Z","timestamp":1589201444000},"page":"104861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Diabetes and calcification: The potential role of anti-diabetic drugs on vascular calcification regression"],"prefix":"10.1016","volume":"158","author":[{"given":"Sounak","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanbing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1570161115666170310092202","article-title":"Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white?","volume":"16","author":"Cianciolo","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2337\/dc13-0997","article-title":"Ideal cardiovascular health and the prevalence and progression of coronary artery calcification in adults with and without type 1 diabetes","volume":"37","author":"Alman","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2006.09.046","article-title":"Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management","volume":"49","author":"Berry","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/ATVBAHA.116.306256","article-title":"Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus","volume":"37","author":"Yahagi","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/ATVBAHA.116.306258","article-title":"Arterial calcification in diabetes mellitus: preclinical models and translational implications","volume":"37","author":"Stabley","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"15","key":"10.1016\/j.phrs.2020.104861_bib0030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tcm.2014.10.021","article-title":"Vascular calcification: mechanisms of vascular smooth muscle cell calcification","volume":"25","author":"Leopold","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2020.104861_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cca.2014.08.034","article-title":"SFBC\/SN joined working group on vascular calcifications, Vascular calcification: from pathophysiology to biomarkers","volume":"438","author":"Evrard","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature","volume":"106","author":"Yan","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2020.104861_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vph.2016.05.014","article-title":"Where do we stand on vascular calcification?","volume":"84","author":"Bostr\u00f6m","year":"2016","journal-title":"Vascul. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.114.302968","article-title":"Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus","volume":"114","author":"Heath","year":"2014","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/nu9020152","article-title":"Diabetes mellitus and younger age are risk factors for hyperphosphatemia in peritoneal Dialysis patients","volume":"9","author":"Imtiaz","year":"2017","journal-title":"Nutrients."},{"key":"10.1016\/j.phrs.2020.104861_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12882-015-0103-8","article-title":"Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients","volume":"16","author":"Shang","year":"2015","journal-title":"BMC Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13510002.2016.1215643","article-title":"Hyperglycaemia, oxidative stress and inflammatory markers","volume":"22","author":"Butkowski","year":"2017","journal-title":"Redox Rep."},{"issue":"11","key":"10.1016\/j.phrs.2020.104861_bib0075","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","article-title":"Macrophage apoptosis and Efferocytosis in the pathogenesis of atherosclerosis","volume":"80","author":"Linton","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.phrs.2020.104861_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camar\u00e9","year":"2017","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0085","doi-asserted-by":"crossref","DOI":"10.7150\/thno.18407","article-title":"Interleukin-32\u03b1 inhibits endothelial inflammation, vascular smooth muscle cell activation, and atherosclerosis by upregulating Timp3 and Reck through suppressing microRNA-205 biogenesis","volume":"7","author":"Son","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.phrs.2020.104861_bib0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/cvr\/cvs371","article-title":"Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout","volume":"97","author":"Yao","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2020.104861_bib0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2172-13-19","article-title":"High glucose concentrations induce TNF-\u03b1 production through the down-regulation of CD33 in primary human monocytes","volume":"13","author":"Gonzalez","year":"2012","journal-title":"BMC Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jdi.12519","article-title":"Association between interleukin-19 and angiopoietin-2 with vascular complications in type 2 diabetes","volume":"7","author":"Li","year":"2016","journal-title":"J. Diabetes Investig."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/03008200903019703","article-title":"TNF-alpha upregulates expression of BMP-2 and BMP-3 genes in the rat dental follicle\u2014implications for tooth eruption","volume":"51","author":"Yao","year":"2010","journal-title":"Connect. Tissue Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1744-9987.2010.00886.x","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification","volume":"15","author":"Chasseraud","year":"2011","journal-title":"Ther. Apher. Dial."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbrc.2009.12.027","article-title":"Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction","volume":"391","author":"Lee","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.40","article-title":"Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression","volume":"82","author":"Zhao","year":"2012","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.phrs.2020.104861_bib0125","first-page":"45","article-title":"Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links","volume":"11","author":"Oguntibeju","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0130","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/en.2012-1216","article-title":"TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts","volume":"153","author":"Lai","year":"2012","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/ATVBAHA.110.220038","article-title":"Vascular calcification: it\u2019s all the RAGE!","volume":"31","author":"Towler","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2020.104861_bib0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fphar.2017.00798","article-title":"NF-\u03ba\u03b2: a potential target in the management of vascular complications of diabetes","volume":"8","author":"Suryavanshi","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/ATVBAHA.116.306258","article-title":"Arterial calcification in diabetes mellitus: preclinical models and translational implications","volume":"37","author":"Stabley","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10157-018-1666-z","article-title":"JAK2\/STAT3\/BMP-2 axis and NF-\u03baB pathway are involved in erythropoietin-induced calcification in rat vascular smooth muscle cells","volume":"23","author":"He","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"issue":"14","key":"10.1016\/j.phrs.2020.104861_bib0155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.febslet.2012.04.030","article-title":"BMP signaling in vascular diseases","volume":"586","author":"Cai","year":"2012","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCRESAHA.110.219071","article-title":"Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification","volume":"107","author":"Yao","year":"2010","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/biom9100534","article-title":"Interplay between BMPs and reactive oxygen species in cell signaling and pathology","volume":"9","author":"S\u00e1nchez-de-Diego","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2020.104861_bib0170","article-title":"The role of matrix Gla protein (MGP) in vascular calcification","volume":"15","author":"Bjorklund","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2020.104861_bib0175","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3389\/fphys.2019.01584","article-title":"Zinc inhibits HIF-Prolyl hydroxylase inhibitor-aggravated VSMC calcification induced by high phosphate","volume":"10","author":"Nagy","year":"2020","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.115.306341","article-title":"Transcription factor Runx2 promotes aortic fibrosis and stiffness in type 2 diabetes mellitus","volume":"117","author":"Raaz","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2020.104861_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110228","article-title":"High-phosphorus environment promotes calcification of A7R5 cells induced by hydroxyapatite nanoparticles","volume":"107","author":"Liu","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"12","key":"10.1016\/j.phrs.2020.104861_bib0190","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.2337\/db14-0326","article-title":"Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets","volume":"63","author":"Cheng","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0195","first-page":"33","article-title":"Osteoporosis and vascular calcification: a shared scenario","volume":"32","author":"Garc\u00eda-G\u00f3mez","year":"2020","journal-title":"Clin. Investig. Arterioscler."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12967-017-1190-z","article-title":"A novel role of cellular interactions in vascular calcification","volume":"15","author":"Bardeesi","year":"2017","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0205","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/01.ATV.0000220441.42041.20","article-title":"Molecular mechanisms of vascular calcification: lessons learned from the aorta","volume":"26","author":"Shao","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0210","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. Version 2","volume":"115","author":"Shao","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0215","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1002\/jcb.27942","article-title":"Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2","volume":"120","author":"Wei","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0220","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1159\/000366400","article-title":"Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt\/\u03b2-catenin pathway","volume":"34","author":"Rong","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2012.03.002","article-title":"Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists","volume":"26","author":"Chatrou","year":"2012","journal-title":"Blood Rev."},{"issue":"January (24)","key":"10.1016\/j.phrs.2020.104861_bib0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-014-0164-1","article-title":"Erratum: vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein","volume":"14","author":"Liabeuf","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0235","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db10-1220","article-title":"The RANKL\/RANK\/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy","volume":"60","author":"Ndip","year":"2011","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.phrs.2020.104861_bib0240","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.108.189001","article-title":"RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway","volume":"104","author":"Panizo","year":"2009","journal-title":"Circ. Res."},{"issue":"Pt A","key":"10.1016\/j.phrs.2020.104861_bib0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.biocel.2016.06.009","article-title":"RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release","volume":"77","author":"Davenport","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0250","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000341216","article-title":"RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-\u03b1","volume":"49","author":"Deuell","year":"2012","journal-title":"J. Vasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11154-015-9310-7","article-title":"Angiogenesis in diabetes and obesity","volume":"16","author":"Cheng","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0260","first-page":"290","article-title":"Metabolic regulation of angiogenesis in diabetes and aging","volume":"32","author":"Sawada","year":"2017","journal-title":"Physiology Bethesda (Bethesda)"},{"issue":"7492","key":"10.1016\/j.phrs.2020.104861_bib0265","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature13146","article-title":"Endothelial Notch activity promotes angiogenesis and osteogenesis in bone","volume":"507","author":"Ramasamy","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0270","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3892\/or.2017.5998","article-title":"SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab\u2011resistant ovarian cancer model","volume":"38","author":"Su","year":"2017","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0275","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1111\/jcmm.14369","article-title":"Enhanced ROBO4 is mediated by up-regulation of HIF-1\u03b1\/SP1 or reduction in miR-125b-5p\/miR-146a-5p in diabetic retinopathy","volume":"23","author":"Gong","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0280","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007555","article-title":"Sp1 plays an important role in vascular calcification both in vivo and in vitro","volume":"7","author":"Zhang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.phrs.2020.104861_bib0285","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.freeradbiomed.2003.08.018","article-title":"Hyperglycemia increases mitochondrial superoxide in retina and retinal cells","volume":"35","author":"Du","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.104861_bib0290","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.freeradbiomed.2003.08.018","article-title":"Hyperglycemia increases mitochondrial superoxide in retina and retinal cells","volume":"35","author":"Du","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0295","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/1389450054021981","article-title":"Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress","volume":"6","author":"Caldwell","year":"2005","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0300","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jdiacomp.2015.12.017","article-title":"Diabetes medications: impact on inflammation and wound healing","volume":"30","author":"Salazar","year":"2016","journal-title":"J. Diabetes Complications"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-017-0509-7","article-title":"Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients","volume":"16","author":"Mary","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"10.1016\/j.phrs.2020.104861_bib0310","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/15384101.2017.1310353","article-title":"Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab","volume":"16","author":"Cuy\u00e0s","year":"2017","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183506","article-title":"Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis","volume":"12","author":"Ara\u00fajo","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.kint.2018.01.027","article-title":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder","volume":"94","author":"Neven","year":"2018","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.phrs.2020.104861_bib0325","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1139\/cjpp-2014-0353","article-title":"Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes,740","volume":"93","author":"Rochette","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104861_bib0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7754\/Clin.Lab.2019.190148","article-title":"TGF-\u03b2 signaling induces the expression of OPN in blood vessel endothelial cells","volume":"65","author":"Jiang","year":"2019","journal-title":"Clin. Lab."},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0335","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1210\/en.2013-1002","article-title":"Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway","volume":"154","author":"Cao","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2020.104861_bib0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2018.08.012","article-title":"Restoring mitochondrial biogenesis with metformin attenuates \u03b2-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4\/oxidative stress-mediated apoptosis","volume":"479","author":"Ma","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.phrs.2020.104861_bib0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lfs.2018.11.008","article-title":"Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway","volume":"216","author":"Zheng","year":"2019","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0350","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/QAD.0b013e32834f33cc","article-title":"Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome","volume":"26","author":"Fitch","year":"2012","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0355","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.116.025483","article-title":"Diabetes prevention program research group, effect of long-term metformin and lifestyle in the diabetes prevention program and its outcome study on coronary artery calcium","volume":"136","author":"Goldberg","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0360","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/dc15-0658","article-title":"Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes","volume":"38","author":"Xu","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0365","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/etm.2016.3996","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 inhibits vascular calcification by upregulating Klotho","volume":"13","author":"Cheng","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0370","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1465-9921-13-90","article-title":"Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies","volume":"13","author":"Seidel","year":"2012","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0375","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.28000","article-title":"Stimulation of nuclear receptor peroxisome proliferator-activated receptor-\u03b3 limits NF-\u03baB-dependent inflammation in mouse cystic fibrosis biliary epithelium","volume":"62","author":"Scirpo","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0380","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.3892\/mmr.2017.7308","article-title":"Effect of pioglitazone on the calcification of rat vascular smooth muscle cells through the downregulation of the Wnt\/\u03b2\u2011catenin signaling pathway","volume":"16","author":"Gao","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.HYP.0000171472.24422.33","article-title":"Pioglitazone improves aortic wall elasticity in a rat model of elastocalcinotic arteriosclerosis","volume":"46","author":"Gaillard","year":"2005","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2020.104861_bib0390","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0003-4509(07)90035-8","article-title":"Importance de l\u2019activation des PPARgamma dans la pharmacologie de la rigidit\u00e9 art\u00e9rielle [Pioglitazone protects against elastocalcinosis and improves aortic wall elasticity]","volume":"65","author":"Lartaud","year":"2007","journal-title":"Ann. Pharm. Fr."},{"issue":"13","key":"10.1016\/j.phrs.2020.104861_bib0395","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/eurheartj\/ehl079","article-title":"TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone","volume":"27","author":"Martens","year":"2006","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00592-008-0054-7","article-title":"Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes","volume":"46","author":"Vijay","year":"2009","journal-title":"Acta Diabetol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0405","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-0031-1275704","article-title":"Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load","volume":"43","author":"Derosa","year":"2011","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104861_bib0410","first-page":"409","article-title":"Sulfonylurea","volume":"73","author":"Usuda","year":"2015","journal-title":"Nihon Rinsho"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0415","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0975-3583.91592","article-title":"Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits","volume":"3","author":"Hadi","year":"2012","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0425","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/path.4548","article-title":"Macrophage PPAR\u03b3 and impaired wound healing in type 2 diabetes","volume":"236","author":"Mirza","year":"2015","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104861_bib0430","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2337\/db13-0927","article-title":"Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice","volume":"63","author":"Mirza","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0435","doi-asserted-by":"crossref","first-page":"E658","DOI":"10.1152\/ajpendo.00204.2019","article-title":"Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents","volume":"317","author":"Schinzari","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.phrs.2020.104861_bib0440","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.metabol.2004.06.013","article-title":"Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy","volume":"53","author":"Putz","year":"2004","journal-title":"Metabolism"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.104861_bib0445","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2152\/jmi.53.87","article-title":"Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis","volume":"53","author":"Koshiba","year":"2006","journal-title":"J. Med. Invest."},{"issue":"9","key":"10.1016\/j.phrs.2020.104861_bib0450","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/ATVBAHA.110.207696","article-title":"Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study","volume":"30","author":"Davidson","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0455","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.numecd.2019.07.010","article-title":"Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus","volume":"29","author":"Barchetta","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/14656566.2015.978289","article-title":"A review of gliptins for 2014","volume":"16","author":"Scheen","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0465","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/met.2017.0057","article-title":"Mast cell and M1 macrophage infiltration and local pro-inflammatory factors were attenuated with incretin-based therapies in obesity-related glomerulopathy","volume":"15","author":"He","year":"2017","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.phrs.2020.104861_bib0470","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12933-014-0153-4","article-title":"Exenatide can inhibit calcification of human VSMCs through the NF-kappaB\/RANKL signaling pathway","volume":"13","author":"Zhan","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2020.104861_bib0475","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12933-016-0414-5","article-title":"Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice","volume":"15","author":"Manrique","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2020.104861_bib0480","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2017.03.003","article-title":"Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice","volume":"96\u201398","author":"Salim","year":"2017","journal-title":"Vascul. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0485","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4149\/gpb_2019034","article-title":"Effects of nicorandil on vascular and renal dysfunctions in adenine-induced nephropathy: possible underlying mechanisms","volume":"38","author":"Hussein","year":"2019","journal-title":"Gen. Physiol. Biophys."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2020.104861_bib0490","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vph.2011.03.001","article-title":"Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways","volume":"55","author":"Shah","year":"2011","journal-title":"Vascul. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0495","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvs246","article-title":"Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition","volume":"96","author":"Kr\u00f6ller-Sch\u00f6n","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2020.104861_bib0500","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3389\/fphar.2019.01568","article-title":"Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0505","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FJC.0b013e31826be204","article-title":"Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats","volume":"60","author":"Mason","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0510","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1210\/jc.2017-01949","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia","volume":"103","author":"Christensen","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2020.104861_bib0515","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5783639","article-title":"The glucagon-like Peptide-1 receptor agonist Exendin-4 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption via inhibition of TNF-\u03b1 expression in macrophages","volume":"2018","author":"Shen","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2020.104861_bib0520","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5783639","article-title":"The glucagon-like peptide-1 receptor agonist exendin-4 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption via inhibition of TNF-\u03b1 expression in macrophages","volume":"2018","author":"Shen","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0525","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164255","article-title":"SAIS study group, a randomized controlled trial comparing the effects of sitagliptin and glimepiride on endothelial function and metabolic parameters: sapporo athero-incretin study 1 (SAIS1)","volume":"11","author":"Nomoto","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0535","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-016-0493-3","article-title":"A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes","volume":"16","author":"Jax","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0540","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/dia.2013.0223","article-title":"Cardiovascular disease and the use of insulin","volume":"15","author":"Kramer","year":"2013","journal-title":"Diabetes Technol. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0545","first-page":"3257","article-title":"Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?","volume":"86","author":"Dandona","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.phrs.2020.104861_bib0550","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1210\/jc.2012-1112","article-title":"Cardiovascular benefits of exogenous insulin","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0555","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.2337\/db12-1127","article-title":"Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo","volume":"62","author":"Tessari","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0560","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0565","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-14-1137","article-title":"The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes","volume":"173","author":"Davenport","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0570","doi-asserted-by":"crossref","first-page":"H1058","DOI":"10.1152\/ajpheart.00047.2006","article-title":"Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin","volume":"292","author":"Olesen","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0575","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2012.01.035","article-title":"Endothelial insulin receptor expression in human atherosclerotic plaques: linking micro- and macrovascular disease in diabetes?","volume":"222","author":"Rensing","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0580","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-14-1137","article-title":"The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes","volume":"173","author":"Davenport","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0585","doi-asserted-by":"crossref","first-page":"H1166","DOI":"10.1152\/ajpheart.00464.2019","article-title":"Persistent insulin signaling coupled with restricted PI3K activation causes insulin-induced vasoconstriction","volume":"317","author":"Olver","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0590","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/HJH.0000000000001161","article-title":"Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease","volume":"35","author":"Larivi\u00e8re","year":"2017","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0595","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1076029618764846","article-title":"The value of big Endothelin-1 in the assessment of the severity of coronary artery calcification","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0600","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pcad.2019.07.005","article-title":"Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes","volume":"62","author":"Garg","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"10166","key":"10.1016\/j.phrs.2020.104861_bib0605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2020.104861_bib0610","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/1060028018757407","article-title":"Assessment of cardiovascular risk with glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes using an alternative measure to the hazard ratio","volume":"52","author":"Kaneko","year":"2018","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0615","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10557-018-6773-2","article-title":"GLP-1 receptor agonists and cardiovascular disease: a meta-analysis of recent cardiac outcome trials","volume":"32","author":"Jia","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"22","key":"10.1016\/j.phrs.2020.104861_bib0620","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME investigators, empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2020.104861_bib0625","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4020492","article-title":"GLP-1 receptor agonists and cardiovascular disease in patients with type 2 diabetes","author":"Del Olmo-Garcia","year":"2018","journal-title":"J. Diabetes Res."},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0630","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcmg.2017.01.030","article-title":"The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.phrs.2020.104861_bib0635","article-title":"The beneficial actions of SGLT-2 inhibitors beyond management of hyperglycemia","author":"Loutradis","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2020.104861_bib0640","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/ijms18081704","article-title":"The SGLT2 inhibitor luseogliflozin rapidly normalizes aortic mRNA levels of inflammation-related but not lipid-metabolism-related genes and suppresses atherosclerosis in diabetic ApoE KO mice","volume":"18","author":"Nakatsu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0645","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00125-016-4158-2","article-title":"The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -\/- mice fed a western diet","volume":"60","author":"Han","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2020.104861_bib0650","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6305735","article-title":"The SGLT-2 inhibitor dapagliflozin has a therapeutic effect on atherosclerosis in diabetic ApoE-\/- mice","volume":"2016","author":"Leng","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0655","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10557-018-6778-x","article-title":"Combined SGLT2 and DPP4 inhibition reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic nephropathy in mice with type 2 diabetes","volume":"32","author":"Birnbaum","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0660","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-019-0839-8","article-title":"How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial","volume":"18","author":"Bosch","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0665","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12933-017-0564-0","article-title":"Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study","volume":"16","author":"Shigiyama","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104861_bib0670","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2020.104861_bib0675","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bcpt.12974","article-title":"Neuroprotective mechanisms of glucagon-like Peptide-1-based therapies in ischaemic stroke: a systematic review based on pre-clinical studies","volume":"122","author":"Marlet","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0680","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20160803","article-title":"GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction","volume":"131","author":"Pastel","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"15","key":"10.1016\/j.phrs.2020.104861_bib0685","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2018.3024","article-title":"Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"319","author":"Zheng","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2020.104861_bib0690","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/dom.13541","article-title":"Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: a randomized, double-blind, placebo-controlled trial","volume":"21","author":"Liakos","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2020.104861_bib0695","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2011.06.033","article-title":"The relationship between resting heart rate and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"220","author":"Rubin","year":"2012","journal-title":"Atherosclerosis"},{"issue":"15","key":"10.1016\/j.phrs.2020.104861_bib0700","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1042\/CS20171299","article-title":"Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review","volume":"132","author":"Boyle","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.phrs.2020.104861_bib0705","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2261-13-13","article-title":"Advanced glycation end products accelerate rat vascular calcification through RAGE\/oxidative stress","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"issue":"10","key":"10.1016\/j.phrs.2020.104861_bib0710","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1161\/CIRCRESAHA.111.300543","article-title":"Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells","volume":"112","author":"Liu","year":"2013","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0715","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/ATVBAHA.114.303301","article-title":"Overexpression of c1q\/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro","volume":"34","author":"Zhou","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2020.104861_bib0720","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-2006-950397","article-title":"Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose","volume":"38","author":"R\u00f6sen","year":"2006","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.104861_bib0725","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s42000-019-00101-z","article-title":"The effects of acarbose on chemokine and cytokine production in human monocytic THP-1 cells","volume":"18","author":"Lin","year":"2019","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.phrs.2020.104861_bib0730","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2147\/DDDT.S208327","article-title":"Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study","volume":"13","author":"Mo","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2020.104861_bib0735","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2710.2009.01132.x","article-title":"Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin","volume":"35","author":"Derosa","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"12","key":"10.1016\/j.phrs.2020.104861_bib0740","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S2213-8587(16)30267-4","volume":"4","author":"Fr\u00edas","year":"2016","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:15:50Z","timestamp":1760912150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820311695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":148,"alternative-id":["S1043661820311695"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104861","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and calcification: The potential role of anti-diabetic drugs on vascular calcification regression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104861"}}